Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

COVID-19 doesn't make alopecia areata worse.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

An elderly man's hair grew back after a treatment that transferred healthy gut bacteria.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The guide explains how to diagnose and treat hair loss in dogs, covering causes and treatments, with some conditions lacking treatment options.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.